Evidence map›Paper›PMID 42182980›Full record

ReviewCurrent treatment options in neurology2026

Visual Impairment and Driving in Older Adults: A Narrative Review.

Shu Xu, Joshua R Ehrlich, Lindsey B De Lott

Abstract readReview
In one paragraph

Review in Current treatment options in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shu XuInstitute for Social Research, University of Michigan, Ann Arbor, MI USA.
Joshua R EhrlichInstitute for Social Research, University of Michigan, Ann Arbor, MI USA.
Lindsey B De LottMichigan Sensory Health and Aging Research Collaborative (Mi-SHARC), University of Michigan, Ann Arbor, MI USA.

Funding

Automated Quantitative Ulcer Analysis (AQUA): Diagnosing Organism TypesR01EY036418 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sina Farsiu, Maria Anneke Woodward · 2024 to 2026
$2.1M
Sensory Aging, Late-Life Wellbeing, and ADRD Research Infrastructure to Catalyze Practice and PolicyR61AG089063 · NIA · JOHNS HOPKINS UNIVERSITY · PI DEAL, JENNIFER ANNE, EHRLICH, JOSHUA ROBERT · 2024 to 2025
$1.6M
NEI NIH HHS R01 EY036418NIA NIH HHS R61 AG089063
6 · The paper itself

Abstract

Purpose of Review: This narrative review synthesizes current evidence on the relationship between visual impairment and driving safety in older adults, with a focus on the visual functions required for safe driving, the impact of common visual deficits, and current approaches to clinical evaluation and management. Recent Findings: Recent studies have strengthened evidence that visual functions beyond high contrast visual acuity--particularly visual field sensitivity, contrast sensitivity, and visual processing speed--are associated with driving performance and crash risk. Emerging studies also highlight the role of higher-order visuospatial processing and the integration of visual input with cognitive, multisensory, and motor systems. Advances in functional assessment tools and in-vehicle technologies, such as advanced driver-assistance systems, may further enhance evaluation and support driving safety. Summary: Driving safety in older adults with visual impairment is multifactorial and cannot be adequately assessed by a single visual measure. A multidomain approach incorporating visual, cognitive, and functional assessment is essential for clinical decision-making. Management should emphasize treatment of reversible conditions, patient-centered counseling, and referral for functional driving evaluation when appropriate. Future research should focus on developing functionally relevant, real-world measures to better guide clinical practice and policy. Opinion Statement: Driving is a visually intensive activity that plays a central role in maintaining independence, mobility, and social participation for older adults. As global populations age, the number of older drivers is increasing, making safe mobility an important public health concern. Visual impairment is common in later life and may arise from both ocular disease and neurologic conditions affecting the visual pathways or higher-order visual processing. Although driver licensing systems worldwide rely heavily on visual acuity thresholds to determine visual fitness to drive, growing evidence indicates that visual acuity alone provides an incomplete assessment of driving safety. Safe driving depends on the coordinated function of multiple visual domains, including central vision, peripheral vision, contrast sensitivity, motion and depth perception, visual processing speed, and higher-order visuospatial processing. Impairments in these domains may compromise hazard detection, situational awareness, and timely responses to changing traffic conditions, even when central visual acuity remains relatively preserved. In addition, driving performance requires integration of visual input with cognitive, multisensory, and motor systems, which may be affected by neurologic disease and age-related changes in sensory processing. Clinical evaluation of older drivers with visual impairment should therefore extend beyond visual acuity to incorporate multidomain assessment of visual and neurologic function when concerns arise. Management strategies should prioritize treatment of reversible visual conditions, patient counseling regarding adaptive driving behaviors, and referral for functional driving evaluation when appropriate. Ultimately, decisions regarding driving must balance preservation of independence with public safety. Continued research is needed to develop evidence-based screening strategies and policies that better reflect the complex visual demands of real-world driving.

Indexed as

Contrast sensitivityDriving performanceDriving safetyOlder adultsVisual field lossVisual impairment

Identifiers

PMID42182980
PMCPMC13194245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.